Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Allakos board of directors update

    Allakos Inc., San Francisco, Calif. Business: Inflammation Appointed: Robert Alexander, director at Alta Partners; John McKearn, managing director at RiverVest Venture Partners; and Peter Moldt, partner at Novo Ventures

    Published on 12/24/2012
  • AthernoNova management update

    AtheroNova Inc. (OTCBB:AHRO), Irvine, Calif. Business: Cardiovascular Hired: Mark Wedel as SVP of clinical affairs and CMO, formerly VP of clinical development and CMO of Santaris A/S

    Published on 12/24/2012
  • BioDelivery management update

    BioDelivery Sciences International Inc. (NASDAQ:BDSI), Raleigh, N.C. Business: Drug delivery, Neurology, Cancer Hired: George Ng as SVP and general counsel

    Published on 12/24/2012
  • Blend Therapeutics management update

    Blend Therapeutics Inc., Watertown, Mass. Business: Combinatorial biology, Cancer, Inflammation Hired: Mark Iwicki as president, CEO and a director, formerly CEO of the Sunovion Pharmaceuticals Inc. subsidiary of …

    Published on 12/24/2012
  • Celator management update

    Celator Pharmaceuticals Inc., Princeton, N.J. Business: Cancer Hired: Fred Powell as CFO, formerly CFO of OraPharma Inc., which Valeant Pharmaceuticals International Inc. acquired

    Published on 12/24/2012
  • CytoDyn management update

    CytoDyn Inc. (OTCBB:CYDY), Lutz, Fla. Business: Infectious Hired: Michael Mulholland as treasurer, corporate secretary and CFO, formerly CFO of Nautilus Inc. Transitioned: Interim President and CEO Nader Pourhassan to …

    Published on 12/24/2012
  • GeNO management update

    GeNO LLC, Cocoa, Fla. Business: Cardiovascular Hired: Barry Gellman as SVP of engineering Transitioned: Kurt Dasse, a director, to president from EVP

    Published on 12/24/2012
  • IGI management update

    IGI Laboratories Inc. (NYSE-M:IG), Buena, N.J. Business: Drug delivery Hired: Kenneth Miller as SVP of R&D, formerly senior director at the Mylan Technologies Inc. unit of Mylan Inc.

    Published on 12/24/2012
  • InfraReDx management update

    InfraReDx Inc., Burlington, Mass. Business: Diagnostic Hired: Michael Guarasci as CFO, formerly COO of Indus Capital Partners LLC

    Published on 12/24/2012
  • Moderna Therapeutics management update

    Moderna Therapeutics Inc., Cambridge, Mass. Business: Biopharmaceuticals Hired: Stephen Hoge as SVP of corporate development and new drug concepts, effective Jan. 1, 2013, formerly a partner at McKinsey & Co.

    Published on 12/24/2012
  • Naurex board of directors update

    Naurex Inc., Evanston, Ill. Business: Neurology Appointed: Ian Ferrier, an advisor to Savitr Capital; and Norbert Riedel, corporate VP and chief science and innovation officer of Baxter International Inc.

    Published on 12/24/2012
  • NeRRe board of directors update

    NeRRe Therapeutics Ltd., Stevenage, U.K. Business: Gastrointestinal Appointed: Martin Edwards, senior partner at Novo Ventures; and Raj Parekh, general partner at Advent Venture Partners

    Published on 12/24/2012
  • Omni Bio Pharmaceutical management update

    Omni Bio Pharmaceutical Inc. (OTCBB:OMBP), Greenwood Village, Colo. Business: Infectious, Endocrine/Metabolic, Transplant Hired: Bruce Schneider as CEO and a director, effective Jan. 1, 2013, formerly EVP and chief of …

    Published on 12/24/2012
  • Onyx board of directors update

    Onyx Pharmaceuticals Inc. (NASDAQ:ONXX), South San Francisco, Calif. Business: Cancer Appointed: President, CEO and Director N. Anthony Coles as chairman; he replaces Paul Goddard, who remains as lead independent …

    Published on 12/24/2012
  • Sanofi management update

    Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Pharmaceuticals Retiring: Hanspeter Spek as president of global operations, effective mid-2013

    Published on 12/24/2012
  • Trevi Therapeutics board of directors update

    Trevi Therapeutics Inc., New Haven, Conn. Business: Dermatology, Renal Appointed: Cayce Denton, associate at TPG Biotech; and Eran Nadav, managing director at TPG Biotech

    Published on 12/24/2012
  • USDS management update

    United States Diagnostic Standards Inc., Rockville, Md. Business: Diagnostics Hired: Christopher Singer as CEO

    Published on 12/24/2012
  • Aastrom management update

    Aastrom Biosciences Inc. (NASDAQ: ASTM), Ann Arbor, Mich. Business: Gene/Cell therapy Transitioning: Dan Orlando, chief commercial officer, to interim CEO, effective Dec. 14; he replaces Tim Mayleben, who remains a …

    Published on 12/17/2012
  • Alere management update

    Alere Inc. (NYSE:ALR), Waltham, Mass. Business: Diagnostic Hired: Namal Nawana as COO, effective Dec. 30, formerly president of Johnson Johnson's DePuy Synthes Spine Inc. subsidiary

    Published on 12/17/2012
  • Amgen board of directors update

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Business: Biopharmaceuticals Appointed: CEO Robert Bradway as chairman, effective Jan. 1, 2013; he replaces Kevin Sharer, who retired as CEO and chairman in May

    Published on 12/17/2012
  • A.P. Pharma management update

    A.P. Pharma Inc. (OTCBB:APPA), Redwood City, Calif. Business: Drug delivery Hired: Mark Gelder as SVP and CMO, formerly VP and global head of medical affairs at the medical diagnostics business of the GE Healthcare unit…

    Published on 12/17/2012
  • Basilea management update

    Basilea Pharmaceutica AG (SIX:BSLN), Basel, Switzerland Business: Infectious, Dermatology, Cancer Departing: Anthony Man as CEO, effective Dec. 31; he will be succeeded by COO Ronald Scott

    Published on 12/17/2012
  • Biocartis board of directors update

    Biocartis S.A., Lausanne, Switzerland Business: Diagnostic Appointed: Roald Borre from PMV

    Published on 12/17/2012
  • Biohit management update

    Biohit Oyj (HSE:BIOBV), Helsinki, Finland Business: Diagnostic Appointed: Kari Syrajanen as chief medical director

    Published on 12/17/2012
  • Cerapedics board of directors update

    Cerapedics Inc., Westminster, Colo. Business: Musculoskeletal Appointed: Sam Wu, managing director of MedImmune Ventures

    Published on 12/17/2012

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993